BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T140635
CREATED:20170502T034747Z
LAST-MODIFIED:20170502T040051Z
UID:1574-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:2nd European Prefilled Syringes Summit
DESCRIPTION:After the success of our first European Prefilled Syringes Summit\, we are pleased to announce the next edition which shall take place on the 6th & 7th September in Berlin\, Germany. \n \nACI’s European Prefilled Syringes Summit will explore the advancements in regulatory guidelines\, product development\, manufacturing processes\, risk mitigation \, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. There are several elements that pose a severe challenge to the growth of the global prefilled syringes market\, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables\, the potential risk of interaction between prefilled syringes and drugs\, and needle stick prevention. \nKey Topics Include:  \n\nEuropean prefilled syringes market & growth opportunities\nTrends in modern biologics targeting therapeutic classes of drugs that are considered to be the primary growth drivers within the market\nLatest FDA guidelines in receiving PFS & overcoming complex requirements for approval\nSpecialty syringes\, which include prefilled flush syringes\, prefilled diluent systems and contrast agents in prefilled syringe\nConcentrating on Next Generation Smart Devices while Overcoming Traditional Challenges\nManaging the Materials used to Construct Pre-Filled Syringes—Selection and Supply Chain Control\nBalancing biopharmaceutical product portfolio for continual product innovation\, such as incorporating a new delivery component and Creating a lower-risk product development strategy\nUsability: Key Human Factor Attributes & Interactive Considerations.\nThe Drug/Device interface: Integration of the formulation and the device \n\n15% subscriber’s discount available on the registration fee.  \nTo receive the agenda or for the priority registration\, please contact\nMohammad Ahsan on +44 (0)20 3141 0606 or email: mahsan@acieu.net \nConference Fee:               £1\,595 (£240 Discount for all members/subscribers) \nDownload the Brochure : http://www.wplgroup.com/aci/wp-content/uploads/sites/2/2017/03/PPFE2-Agenda_MKT.pdf \nDownload the Brochure Now!
URL:https://www.pharmajournalist.com/event/2nd-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany\, India
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T140635
CREATED:20170623T033647Z
LAST-MODIFIED:20170623T033647Z
UID:2374-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials New England
DESCRIPTION:OCT New England returns to Boston this September with an agenda that hosts new session formats including an ideal pool\, lightning round and workshops. Last year the event saw countless attendees engage in thought leadership presentations and interactive discussions which enabled relationship building and the creation of long lasting relationships. The agenda will address many key themes such as managing vendor contracts and overcoming the challenges of using mobile devices in trials.  \nWe invite you to join us for an event that is promised to be bigger and better than ever. Simply visit the website today to register online http://www.arena-international.com/octnewengland/  
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:sarah.rosenberg@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170907
DTEND;VALUE=DATE:20170909
DTSTAMP:20260515T140635
CREATED:20170619T035153Z
LAST-MODIFIED:20170619T035851Z
UID:2282-1504742400-1504915199@www.pharmajournalist.com
SUMMARY:Life Science Investor Relations Forum
DESCRIPTION:Exl’s Life Science IR Forum\, taking place on September 7-8\, 2017 at the Revere Hotel in Boston\, MA\, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations\, advancements in technology\, more engaged investors and working relationships with advisory boards. Through this event\, IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2rMkxvl
URL:https://www.pharmajournalist.com/event/life-science-investor-relations-forum/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA 02116
ORGANIZER;CN="ExL Events":MAILTO:cbrady@exlevents.com
END:VEVENT
END:VCALENDAR